SELECTION OF NON-BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS DEPENDING ON CLINICAL, LABORATORY AND RADIOLOGICAL CHARACTERISTICS OF RHEUMATOID ARTHRITIS

被引：0
|
作者：
Iaremenko, Oleg [1 ]
Mikitenko, Ganna [1 ]
机构：
[1] Natl Med Univ OO Bogomolets, Kiev, Ukraine
来源：
RHEUMATOLOGY | 2011年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：115 / 116
页数：2
相关论文
共 50 条
  • [1] Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis
    Nash, Peter
    Richette, Pascal
    Gossec, Laure
    Marchesoni, Antonio
    Ritchlin, Christopher
    Kato, Koji
    McDearmon-Blondell, Erin L.
    Lesser, Elizabeth
    McCaskill, Reva
    Feng, Dai
    Anderson, Jaclyn K.
    Ruderman, Eric M.
    [J]. RHEUMATOLOGY, 2022, 61 (08) : 3257 - 3268
  • [2] Efficacy and Safety of Methotrexate in Combination with Other Non-biologic Disease-modifying Antirheumatic Drugs (DMARDs) in Treatment of Rheumatoid Arthritis
    Castrejon, Isabel
    Gibson, Kathryn A.
    Pincus, Theodore
    [J]. BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2013, 71 : S20 - S28
  • [3] Intensification to Triple Therapy Non-Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States from 2009 to 2014
    Sparks, Jeffrey A.
    Krumme, Alexis A.
    Matlin, Olga S.
    Brill, Gregory
    Shrank, William H.
    Choudhry, Niteesh K.
    Solomon, Daniel H.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] ANNUAL TREATMENT COST OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Hosseini, R.
    Brown, L. M.
    Fleming, M.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S110 - S110
  • [5] Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain
    Silva-Fernandez, Lucia
    Perez-Vicente, Sabina
    Auxiliadora Martin-Martinez, Maria
    Lopez-Gonzalez, Ruth
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (06) : 633 - 640
  • [6] Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying antirheumatic drugs for rheumatoid arthritis
    Katchamart, Wanruchada
    Trudeau, Judith
    Phumethum, Veerapong
    Bombardier, Claire
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (04):
  • [7] Comparative Effectiveness of Tofacitinib, Biologic Drugs and Traditional Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Machado, Marina
    Moura, Cristiano
    Behlouli, Hassan
    Curtis, Jeffrey
    Bernatsky, Sasha
    [J]. JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 937 - 938
  • [8] COMPARATIVE EFFECTIVENESS OF TOFACITINIB, BIOLOGIC DRUGS AND TRADITIONAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Moura, C. S.
    Machado, M. A.
    Behlouli, H.
    Curtis, J. R.
    Abrahamowicz, M.
    Bernatsky, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 825 - 826
  • [9] Comparative Effectiveness of Tofacitinib, Biologic Drugs and Traditional Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Machado, Marina
    Moura, Cristiano S.
    Behlouli, Hassan
    Curtis, Jeffiey R.
    Bernatsky, Sasha
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] Survival of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Rosales Rosado, Zulema
    Leon, Leticia
    Freites Nunez, Dalifer
    Font Urgelles, Judit
    Leon Cardenas, Cynthia Milagros
    Vadillo Font, Cristina
    Rodriguez Rodriguez, Luis
    Jover Jover, Juan A.
    Abasolo Alcazar, Lydia
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345